tiprankstipranks
Trending News
More News >
Sarepta Therapeutics (DE:AB3A)
FRANKFURT:AB3A
Germany Market
Advertisement

Sarepta Therapeutics (AB3A) Technical Analysis

Compare
5 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Sarepta Therapeutics’s (AB3A) Moving Averages Convergence Divergence (MACD) indicator is 1.13, suggesting Sarepta Therapeutics is a Sell.
Sarepta Therapeutics’s (AB3A) 20-Day exponential moving average is 17.57, while Sarepta Therapeutics’s (AB3A) share price is €19.32, making it a Buy.
Sarepta Therapeutics’s (AB3A) 50-Day exponential moving average is 17.41, while Sarepta Therapeutics’s (AB3A) share price is €19.32, making it a Buy.

Sarepta Therapeutics (AB3A) Pivot Points

Oct 14, 2025, 01:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.54
19.70
20.04
20.20
20.54
20.70
21.04
Fibonacci
19.70
19.89
20.01
20.20
20.39
20.51
20.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (AB3A) Moving Averages

Oct 14, 2025, 01:52 AM
Period
Simple
Exponential
MA5
19.80Sell
19.40Sell
MA10
18.45Buy
18.63Buy
MA20
16.86Buy
17.57Buy
MA50
16.24Buy
17.41Buy
MA100
18.44Buy
24.43Sell
MA200
49.54Sell
51.28Sell
Sarepta Therapeutics’s (AB3A) 10-Day exponential moving average is 18.63, while Sarepta Therapeutics’s (AB3A) share price is €19.32, making it a Buy.
Sarepta Therapeutics’s (AB3A) 100-Day exponential moving average is 24.43, while Sarepta Therapeutics’s (AB3A) share price is €19.32, making it a Sell.
Sarepta Therapeutics’s (AB3A) stock price is €19.32 and Sarepta Therapeutics’s (AB3A) 50-day simple moving average is 16.24, creating a Buy signal.
Sarepta Therapeutics’s (AB3A) stock price is €19.32 and Sarepta Therapeutics’s (AB3A) 100-day simple moving average is 18.44, creating a Buy signal.
Sarepta Therapeutics’s (AB3A) stock price is €19.32 and Sarepta Therapeutics’s (AB3A) 200-day simple moving average is 49.54, creating a Sell signal.

Sarepta Therapeutics (AB3A) Technical Indicators

Oct 14, 2025, 01:52 AM
Name
Value
Implied Action
RSI (14)
63.13
Neutral
STOCH (9,6)
74.48
Neutral
STOCHRSI (14)
76.66
Neutral
MACD (12,26)
1.13
Sell
ADX (14)
29.47
Neutral
Williams %R
-34.18
Buy
CCI (14)
88.54
Neutral
ATR (14)
0.81
-
Ultimate Oscillator
51.82
Neutral
ROC
20.35
Buy
Sarepta Therapeutics’s (AB3A) Relative Strength Index (RSI) is 63.13, creating a Neutral signal.
Sarepta Therapeutics’s (AB3A) Trend Strength Indicator (ADX) is 29.47, creating a Neutral signal.
Sarepta Therapeutics’s (AB3A) Commodity Channel Index (CCI) is 88.54, creating a Neutral signal.
Sarepta Therapeutics’s (AB3A) Price Rate of Change (ROC) is 20.35, creating a Buy signal.

FAQ

Is AB3A a Buy, Hold, or Sell?
Based on AB3A’s technical indicators, AB3A is a Buy.
    What is AB3A’s RSI (14)?
    AB3A’s RSI (14) is 63.13, which suggests AB3A is a Neutral.
      What is AB3A’s MACD?
      AB3A’s MACD is 1.13, which suggests AB3A is a Sell.
        What is AB3A’s 5-day moving average?
        AB3A’s 5-day moving average is 19.80, which suggests AB3A is a Sell.
          What is AB3A’s 20-day moving average?
          AB3A 20-day moving average is 16.86, which suggests AB3A is a Buy.
            What is AB3A’s 50-day moving average?
            AB3A’s 50-day moving average is 16.24, which suggests AB3A is a Buy.
              What is AB3A’s 200-day moving average?
              AB3A’s 200-day moving average is 49.54, which suggests AB3A is a Sell.
                What is AB3A’s Williams % R (14)?
                AB3A’s Williams % R (14) is -34.18, which suggests AB3A is a Buy.
                  What is AB3A’s CCI (14)?
                  AB3A’s CCI (14) is 88.54, which suggests AB3A is a Neutral.
                    What is the share price of Sarepta Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis